- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Locally Recurrent Rectal Cancer in Hungary
Total 112 results
-
AmgenCompletedLocally Recurrent and Metastatic Breast CancerUnited States, United Kingdom, Denmark, Poland, Belgium, Hungary, Spain, Austria, France, Australia, Netherlands, Finland, India
-
Daehwa Pharmaceutical Co., Ltd.Active, not recruitingRecurrent or Metastatic Breast CancerChina, Korea, Republic of, Serbia, Bulgaria, Hungary
-
ETOP IBCSG Partners FoundationPfizerRecruitingBreast Cancer RecurrentSwitzerland, Italy, France, Spain, Hungary, Austria
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
Hoffmann-La RocheCompleted
-
St. Borbala HospitalBiological Research Centre, SzegedSuspendedColorectal CancerHungary
-
AstraZenecaActive, not recruitingMetastatic Urothelial Cancer | Unresectable Locally Advanced Urothelial CancerUnited States, Italy, Spain, Canada, Hungary, Poland, Argentina, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, India, Japan, Philippines, Russian Federation, China, Taiwan, Israel, Australia, Bulgaria
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedStage IV or Recurrent Non-Small Cell Lung CancerUnited States, Finland, Argentina, France, Italy, Brazil, Greece, Japan, Mexico, Romania, Spain, Sweden, United Kingdom, Australia, Austria, Belgium, Canada, Czechia, Germany, Hungary, Korea, Republic of, Netherlands, Poland, Switzerland and more
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Patient SatisfactionHungary
-
AmgenCompletedCancer | Metastatic Colorectal Cancer | Colorectal Cancer | Neutropenia | Fever | Rectal Cancer | Colon Cancer | Locally AdvancedUnited States, Belgium, Czechia, Canada, Hungary, Poland, Russian Federation, Ukraine, Bulgaria, Romania, Australia, Ireland, France, Slovakia, Latvia, Italy, Mexico
-
Semmelweis UniversityRecruitingHER2-negative Breast CancerHungary
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Mastectomy; LymphedemaHungary
-
St. Borbala HospitalSemmelweis University; St. Borbala Hospital, Department of SurgeryCompletedColorectal Cancer | Insulin ResistanceHungary
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Patient Satisfaction | Mastectomy; LymphedemaHungary
-
Swiss Group for Clinical Cancer ResearchCompletedColorectal CancerSwitzerland, Hungary
-
St. Borbala HospitalNot yet recruitingColorectal Cancer | Lymph Node MetastasesHungary
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, Mexico, Germany, Portugal, Spain, Thailand, Turkey, United Kingdom, Kenya, Hungary, Poland, Colombia, India, Oman, Uganda, United Arab... and more
-
BioNTech SERecruitingRecurrent Head and Neck Cancer | Unresectable Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck CancerGermany, United States, France, United Kingdom, Korea, Republic of, Spain, Poland, Belgium, Brazil, Taiwan, Italy, Canada, Czechia, Australia, Turkey, Mexico, Chile, Argentina, Austria, Hungary, Portugal, Sweden
-
PfizerTerminatedAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid TumorsUnited States, Canada, United Kingdom, Korea, Republic of, Australia, Belgium, Denmark, Hungary, Russian Federation
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Greece, Spain, United States, Israel, France, Japan, Belgium, Poland, China, Singapore, Australia, Hungary, Czechia, Italy, South Africa, Hong Kong, Chile, Brazil, Argentina, Austria, Canada, Germany, Portugal, United Kingdom
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER2/Neu Over-expressing Locally Advanced Breast CancerChina, United States, France, Hungary, Turkey, Japan, Germany, Singapore, Italy, Poland, Spain, United Kingdom, Thailand, Israel, Australia, Belgium, Greece, Argentina, Czech Republic, Mexico, Slovakia
-
Swiss Group for Clinical Cancer ResearchCompletedColorectal CancerSwitzerland, Hungary
-
Epigenomics, IncCompletedColorectal CancerHungary, Germany
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
SanofiTerminatedAnxiety DisordersFrance, Russian Federation, Australia, Germany, Spain, Mexico, Hungary, Italy, Chile
-
AstraZenecaActive, not recruitingLocally Advanced (Inoperable) or Metastatic Breast CancerUnited States, Italy, Spain, Belgium, Hungary, Poland, Canada, France, Germany, Korea, Republic of, Japan, Peru, Russian Federation, United Kingdom, China, Taiwan, Israel, Australia, Argentina
-
Incyte CorporationCompletedMetastatic Melanoma | Unresectable Melanoma | Metastatic Urothelial Cancer | Metastatic Non-small Cell Lung Cancer | Locally Advanced Renal Cell Carcinoma | Locally Advanced Urothelial Cancer | Metastatic Clear-Cell Renal Cell CarcinomaFrance, Spain, United States, Italy, Austria, Romania, Poland, Hungary
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
SynCore Biotechnology Co., Ltd.CompletedPancreatic Adenocarcinoma | Metastatic Pancreas Cancer | Locally Advanced Pancreatic CancerUnited States, Korea, Republic of, Taiwan, France, Hungary, Israel, Russian Federation
-
SanofiCompletedHead and Neck Neoplasms | Neoplasm Metastasis | Neoplasm Recurrence, LocalRussian Federation, United States, Canada, Germany, Hungary, Italy, South Africa, Argentina, Uruguay, Austria, Switzerland, Israel, Belgium, France, Australia, Brazil, Greece, Guadeloupe, Réunion, Spain
-
AstraZenecaCompleted
-
Gilead SciencesCompletedColorectal Neoplasms | Colorectal Cancer | Rectal Cancer | Colon Cancer | Colorectal Carcinoma | Colorectal TumorUnited States, Sweden, Germany, Hungary, Switzerland
-
AstraZenecaCompletedLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Poland, France, Germany, Brazil, Hungary, Netherlands, Bulgaria
-
NovartisCompletedNeoplasm MetastasisHungary
-
Ludwig-Maximilians - University of MunichUnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerGermany, Netherlands, Hungary
-
Kartos Therapeutics, Inc.TerminatedSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentGermany, Spain, France, Australia, United States, Korea, Republic of, Hungary
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedMetastatic Colorectal CancerDenmark, Japan, Belgium, Finland, Hungary, United States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Colorectal CancerAustria, France, Hungary, United Kingdom, Italy, Germany, Spain
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
Genzyme, a Sanofi CompanyCompletedCancer | ColorectalKorea, Republic of, Spain, Hungary, Slovakia, Taiwan, France
-
Hoffmann-La RocheCompleted
-
AstraZenecaCompletedLocally Advanced Cervical CancerUnited States, Taiwan, Korea, Republic of, Brazil, Hungary, India, Japan, Mexico, Peru, Philippines, Poland, Russian Federation, China, Chile, South Africa
-
Hoffmann-La RocheCompleted
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Canada, France, Italy, Spain, United Kingdom, Belgium, Poland, Brazil, Germany, Hungary, Peru, Russian Federation, Turkey, Australia, Chile, Austria, Netherlands, Portugal, Israel, Mexico, Romania, Sweden, Ukraine, Bulgaria, Argenti...
-
Glycotope GmbHCompletedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Epithelial Cancer RecurrentGermany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, United Kingdom
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Germany, Thailand, France, Belgium, China, Argentina, Greece, Turkey, Malaysia, Portugal, Hungary, Brazil, United States, India
-
Servier Affaires MédicalesActive, not recruitingMetastatic Colorectal CancerNetherlands, Belgium, Spain, France, Italy, Sweden, Slovenia, Germany, Argentina, Austria, Croatia, Czechia, Greece, Hungary, Ireland, Portugal, Switzerland, United Kingdom